DRKS00017069招募中不适用
on-interventional prospective research study by d-uo on intravesical instillation of mitomycin C in non-muscle invasive bladder cancer - THUROC
d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)0 个研究点目标入组 500 人开始时间: 2019年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •1. age> = 18 years
- •2. gender: male or female
- •3. Written consent and consent to the processing of personal data given
- •4. Patients with histologically confirmed, non-muscle-invasive urothelial carcinoma of the bladder (typical bladder cancer)
- •5. Patients with planned or performed TUR-B
- •6. Patients with planned instillation therapy with mitomycin C (Urocin®)
排除标准
- •1. Presence of a bladder wall perforation
- •2. Other histological subtype as urothelial carcinoma (e.g., urinary bladder adenocarcinoma, squamous cell carcinoma of bladder)
- •3. cystitis
- •4. Hypersensitivity to mitomycin C or another component of Urocin® according to the SmPC
- •5. Pregnancy or breastfeeding
研究者
相似试验
招募中
不适用
on interventionel prospective study to develop a prognostic scoring system for outcome of autologous transplantation in multiple myeloma (MM).C90Multiple myeloma and malignant plasma cell neoplasmsDRKS00003964niversitätsklinikum Freiburg50
尚未招募
Unknown
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.CTRI/2023/06/054257CognitiveBotics Technologies Private Limited
进行中(未招募)
不适用
APPRECIATERheumatoid arthritisJPRN-jRCTs031210665Kawahito Yutaka55
招募中
2 期
Efficacy of Intraoperative Fluorescence Diagnosis in Meningioma surgeryMeningiomameningiomaJPRN-jRCTs031210158Masahide Matsuda22
招募中
不适用
on-interventional, prospective study to evaluate the predictive potential of early CRP kinetics, in particular the CRP flare-response phenomenon, on the efficacy of immunotherapy in advanced urooncological tumors (renal cell carcinoma, urothelial carcinoma). Prospective Evaluation of the CRP-FLAre phenomenon on Immunotherapy REsponse in Urooncology (FLAIRE).C64C65C66C67C68Malignant neoplasm of kidney, except renal pelvisMalignant neoplasm of renal pelvisMalignant neoplasm of ureterMalignant neoplasm of bladderMalignant neoplasm of other and unspecified urinary organsDRKS00031957Klinik und Poliklinik fu¨r Urologie und Kinderurologie Universitätsklinikum Bonn200
